Classifies gabapentin as a controlled substance. S T A T E O F N E W Y O R K _____ 10321 I N A S S E M B L Y April 10, 2018 _____ Introduced by M. of A. McDONALD -- read once and referred to the Commit- tee on Health AN ACT to amend the public health law, in relation to establishing a schedule VI of drugs and other substances, to including gabapentin as a drug to be monitored through the Gabapentin isn’t a narcotic or federally controlled substance, but it is regulated and recognized as a controlled substance in certain states. Gabapentin is approved by the Food and Gabapentin is not currently listed as a controlled substance under the Controlled Substances Act of 1970. 11 Several state boards of pharmacy, as outlined in Supplemental Table 2 and Figure 1, have independently reclassified gabapentin under state pharmacy rules as a Schedule V drug. Other states have required gabapentin use to be monitored Gabapentin (Neurontin) is not a narcotic or federally controlled substance by the DEA as of November 2022, but it is classified as a Schedule V controlled substance in certain states. 80.71 Practitioners; dispensing controlled substances 71 80.72 Issuance of official New York State prescription forms 73 80.73 Pharmacists; dispensing schedule II substances and certain other controlled substances 74 80.74 . Pharmacists; dispensing schedule III, IV and V controlled substances 78 This bill reclassifies the drug gabapentin as a controlled substance in New York. It amends the public health law to add gabapentin to Schedule VI, which will require it to be monitored through the state's prescription monitoring program. Classifies gabapentin as a controlled substance. law that includes non-narcotic drugs such as gabapentin. toring program. Section three establishes the effective date. Gabapentin is a popular prescription drug that is approved by the U.S. Food and Drug Administration (FDA) for nerve pain and epilepsy treat- ment. Gabapentin is frequently combined with other substances for the purpose of potentiating the effects of the drugs or achieving a “high.” Studies have identified various substances that are commonly abused in combination with gabapentin, including alcohol, opioids, benzodiazepines, antidepressants, and other CNS depressants 13,14,15. The number of states placing gabapentin on the controlled substance list or in their required monitoring program is growing and three more states are debating whether to add gabapentin as a controlled substance or to their mandated reporting programs (DE, NY, and WI). Adds gabapentin to the prescription monitoring program. S T A T E O F N E W Y O R K _____ 3823 2019-2020 Regular Sessions I N A S S E M B L Y January 31, 2019 _____ Introduced by M. of A. McDONALD, D'URSO, ENGLEBRIGHT, RIVERA, TAYLOR, SEAWRIGHT, McDONOUGH, MORINELLO, LAWRENCE, MONTESANO, BLANKENBUSH, BRAUNSTEIN, WILLIAMS, ARROYO, GOTTFRIED, JAFFEE, BLAKE -- Multi-Spon- sored by -- M. of A Electronic Prescribing and Dispensing of Controlled Substances is now permissible in New York State Effective March 27, 2013 – Updated April 2013 Amendments to Title 10 NYCRR Part 80 Rules and Regulations on Controlled Substances have been adopted and became effective as final regulations on March 27, 2013. At the national level, gabapentin is not classified as a controlled substance under the Controlled Substances Act (CSA). This means it is not subject to the stringent regulations that apply to opioids or benzodiazepines, which are categorized based on their potential for abuse, medical use, and safety. Gabapentin isn’t a controlled substance according to the federal government. But several states have passed their own laws classifying gabapentin a schedule V (schedule 5) controlled substance. Combining gabapentin and opioids can be extremely dangerous. Establishes a schedule VI of drugs and other substances; includes gabapentin as a drug to be monitored through the prescription monitoring program; makes conforming changes; and directs the commissioner of health to promulgate regulations necessary or desirable to classify gabapentin and its chemical equivalents as a scheduled substance for the As evidenced by drug screens, Gabapentin is usually the most predominant drug present in those undergoing opioid/heroin treatments (i.e. bupre- norphine) and also present in a majority of opioid and heroin overdose deaths. single substance pharmaceutical exposures (i.e., the number of human exposure cases that identified only one substance), gabapentin was identified as a single substance in 6,955 cases in 2022. With respect to medical outcomes associated with gabapentin calls to poison control centers in 2022, gabapentin was associated with 6 deaths, 164 § 3306. Schedules of controlled substances. There are hereby established five schedules of controlled substances, to be known as schedules I, II, III, IV and V respectively. Such schedules shall consist of the following substances by whatever name or chemical designation known: Schedule I. (a) Schedule I shall consist of the drugs and other New York S3906 2019-2020 Classifies gabapentin as a controlled substance In addition to this requirement, practitioners must comply with all other applicable Federal and State laws, including New York State regulations for consulting the Prescription Monitoring Program (PMP) Registry when writing prescriptions for Schedule II, III, and IV controlled substances, and the use of electronic prescribing. New York State Senator Gustavo Rivera (D-Bronx) photographed in New York on Aug. 4, 2021. the Drug Policy Alliance pushed back on the categorization of gabapentin as a controlled substance
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |